UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2011-11, Vol.58 (3), p.297

2011

Volltextzugriff (PDF)

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)

AIDS (London), 2002-07, Vol.16 (11), p.1479-1487

2002

Volltextzugriff (PDF)

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production

The Journal of immunology (1950), 1998-10, Vol.161 (8), p.4236-4243

1998

Volltextzugriff (PDF)

Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV

Antiviral therapy, 2012, Vol.17 (5), p.869-881

2012

Volltextzugriff (PDF)

Preclinical Studies of Pf-04849285, An Interferon-α8 Fusion Protein for the Treatment of HCV

Antiviral therapy, 2012-07, Vol.17 (5), p.869-881

2012

Volltextzugriff (PDF)

Preclinical studies of PF-04849285, an interferon- alpha 8 fusion protein for the treatment of HCV

Antiviral therapy, 2012-01, Vol.17 (5), p.869-881

2012

Volltextzugriff (PDF)

Therapeutic potential of TNF-α inhibitors old and new

Drug discovery today, 1997-07, Vol.2 (7), p.273-282

1997

Volltextzugriff (PDF)

Low CD4 counts rather than superantigenic-like effects account for differences in expressed T-cell receptor (TCR) repertoires between HIV-1 seropositive long-term non-progressors

British journal of haematology, 1998-09, Vol.102 (5), p.1187

1998

Volltextzugriff (PDF)

Low CD4 counts rather than superantigenicalike effects account for differences in expressed Tacell receptor (TCR) repertoires between HIVa1 seropositive longaterm nonaprogressors and individuals with progressive disease

British journal of haematology, 1998-08, Vol.102 (5), p.1187-1196

1998

Volltextzugriff (PDF)

Low CD4 counts rather than superantigenic‐like effects account for differences in expressed T‐cell receptor (TCR) repertoires between HIV‐1 seropositive long‐term non‐progressors and individuals with progressive disease

British journal of haematology, 1998-09, Vol.102 (5), p.1187-1196

1998

Volltextzugriff (PDF)

Studies on the targeting and processing of proricin

Westby, Michael

1991

Volltextzugriff (PDF)

Recombinant proricin binds galactose but does not depurinate 28 S ribosomal RNA

FEBS letters, 1989-09, Vol.255 (1), p.15-20

1989

Volltextzugriff (PDF)

Aging, exercise, and endothelin-1 system activation

Westby, Christian Michael

2009

Volltextzugriff (PDF)

Preparation and characterization of recombinant proricin containing an alternative protease-sensitive linker sequence

Bioconjugate chemistry, 1992-09, Vol.3 (5), p.375-381

1992

Volltextzugriff (PDF)

Chapter 27 Genetics and molecular biology of AIDS virus

Principles of Medical Biology, 1998, Vol.9, p.453-478

1998

Volltextzugriff (PDF)

The role of host immune responses in determining the outcome of HIV infection

Immunology today (Amsterdam. Regular ed.), 1996-03, Vol.17 (3), p.120-126

1996

Volltextzugriff (PDF)

CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-{alpha} Production

The Journal of immunology (1950), 1998-10, Vol.161 (8), p.4236

1998

Volltextzugriff (PDF)

Left ventricular remodeling during and after 60 days of sedentary head-down bed rest

Journal of applied physiology (1985), 2016-04, Vol.120 (8), p.956-964

2016

Volltextzugriff (PDF)

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

Circulation (New York, N.Y.), 2003-04, Vol.107 (15), p.1985-1990

2003

Volltextzugriff (PDF)

Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry

Journal of Virology, 2007-03, Vol.81 (5), p.2359-2371

2007

Volltextzugriff (PDF)

Guidelines for evaluating performance of oyster habitat restoration

Restoration ecology, 2015-11, Vol.23 (6), p.737-745

2015

Volltextzugriff (PDF)

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

The New England journal of medicine, 2008-10, Vol.359 (14), p.1442-1455

2008

Volltextzugriff (PDF)

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)

European heart journal, 2010-12, Vol.31 (23), p.2915-2957

2010

Volltextzugriff (PDF)

Officially social: Developing a social media crisis communication strategy for USGS Volcanoes during the 2018 Kīlauea eruption

Frontiers in communication, 2023-03, Vol.8

2023

Volltextzugriff (PDF)

HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

Journal of Virology, 2011-05, Vol.85 (9), p.4330-4342

2011

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(34)
Female
(24)
Biological And Medical Sciences
(22)
Male
(22)
Medical Sciences
(18)
Adult
(14)
Middle Aged
(14)
Infectious Diseases
(11)
Animals
(9)
Cardiac & Cardiovascular Systems
(9)
Cardiovascular System & Cardiology
(9)
Hiv Infections - Drug Therapy
(9)
Virology
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Hiv-1 - Drug Effects
(8)
Immunology
(8)
Aged
(7)
Antiviral Agents
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production

Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV

Preclinical Studies of Pf-04849285, An Interferon-α8 Fusion Protein for the Treatment of HCV

Preclinical studies of PF-04849285, an interferon- alpha 8 fusion protein for the treatment of HCV

Therapeutic potential of TNF-α inhibitors old and new

Low CD4 counts rather than superantigenic-like effects account for differences in expressed T-cell receptor (TCR) repertoires between HIV-1 seropositive long-term non-progressors

Low CD4 counts rather than superantigenicalike effects account for differences in expressed Tacell receptor (TCR) repertoires between HIVa1 seropositive longaterm nonaprogressors and individuals with progressive disease

Low CD4 counts rather than superantigenic‐like effects account for differences in expressed T‐cell receptor (TCR) repertoires between HIV‐1 seropositive long‐term non‐progressors and individuals with progressive disease

Studies on the targeting and processing of proricin

Recombinant proricin binds galactose but does not depurinate 28 S ribosomal RNA

Aging, exercise, and endothelin-1 system activation

Preparation and characterization of recombinant proricin containing an alternative protease-sensitive linker sequence

Chapter 27 Genetics and molecular biology of AIDS virus

The role of host immune responses in determining the outcome of HIV infection

CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-{alpha} Production

Left ventricular remodeling during and after 60 days of sedentary head-down bed rest

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry

Guidelines for evaluating performance of oyster habitat restoration

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)

Officially social: Developing a social media crisis communication strategy for USGS Volcanoes during the 2018 Kīlauea eruption

HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

Suchergebnisse filtern